Drug Profile
KF 19514
Alternative Names: KF19514Latest Information Update: 16 Oct 2006
Price :
$50
*
At a glance
- Originator Kyowa Hakko
- Class Antiasthmatics; Naphthyridines; Small molecules
- Mechanism of Action Type 1 cyclic nucleotide phosphodiesterase inhibitors; Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis; Asthma
Most Recent Events
- 16 Oct 2006 Discontinued - Preclinical for Allergic rhinitis in Japan (PO)
- 16 Oct 2006 Discontinued - Preclinical for Asthma in Japan (PO)
- 09 Nov 1999 Preclinical development for Allergic rhinitis in Japan (PO)